Repligen

Repligen Corporation
TypePublic
Nasdaq: RGEN
S&P 400 Component
IndustryBiotechnology

Pharmaceutical

Laboratory equipment
Founded1981 (1981)
FoundersAlexander Rich
Paul Schimmel
Headquarters
Waltham, Massachusetts
,
United States
Key peopleOlivier Loeillot (president and CEO)
ProductsMaterials used in the manufacture of biological drugs
RevenueIncreaseUS$738 million (2025)
Number of employees
c. 2,000 (2025)
Websiterepligen.com

Repligen Corporation is an American life sciences company that develops and manufactures products used in biological drug manufacturing. The company is headquartered in Waltham, Massachusetts, and is listed on the Nasdaq under the symbol RGEN.